Cingulate Inc.
General ticker "CING" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $12.4M (TTM average)
Cingulate Inc. follows the US Stock Market performance with the rate: 1.9%.
Estimated limits based on current volatility of 2.5%: low 3.79$, high 3.99$
Factors to consider:
- Total employees count: 13 (-13.3%) as of 2023
- Top business risk factors: Insufficient funding, Economic downturns and volatility, Labor/talent shortage/retention, Regulatory and compliance, Cybersecurity threats
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.00$, 44.79$]
- 2024-12-30 to 2025-12-30 estimated range: [1.56$, 11.47$]
Financial Metrics affecting the CING estimates:
- Negative: with PPE of -0.2 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -14.57 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -196.75 <= 18.93
- Negative: negative Industry operating income (median)
- Negative: -0.75 < Inventory ratio change, % of 0
Short-term CING quotes
Long-term CING plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $20.68MM | $17.50MM | $22.76MM |
| Operating Income | $-20.68MM | $-17.50MM | $-22.76MM |
| Non-Operating Income | $-0.03MM | $-0.17MM | $-0.78MM |
| R&D Expense | $8.41MM | $9.00MM | $15.49MM |
| Income(Loss) | $-20.71MM | $-17.68MM | $-23.53MM |
| Profit(Loss)* | $-20.74MM | $-17.68MM | $-23.53MM |
| Stockholders Equity | $20.84MM | $3.88MM | $-6.87MM |
| Inventory | $0.00MM | $0.10MM | $0.01MM |
| Assets | $22.89MM | $11.41MM | $3.49MM |
| Operating Cash Flow | $-10.43MM | $-15.88MM | $-15.03MM |
| Capital expenditure | $0.81MM | $0.15MM | $0.22MM |
| Investing Cash Flow | $-0.81MM | $-0.15MM | $-0.22MM |
| Financing Cash Flow | $26.54MM | $4.90MM | $9.95MM |
| Earnings Per Share** | $-14.67 | $-12.50 | $-10.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.